Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: therapeutic potential for type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples